Abstract
Atopic dermatitis is characterized by impaired skin and mucous membrane barrier function. Measures improving barrier integrity decrease the influence of environmental factors that might exacerbate inflammation. Ten adult patients with mild-to-moderate atopic dermatitis consumed for three months fermented with potent antioxidative probiotic, L. fermentum ME-3 (DSM 14241) goat milk 200 mg/day. A control group consisted of six patients, not supplemented by probiotic. All patients used emollients regularly. Skin iron levels, glutathione redox ratios (GSSG/GSH), diene conjugate (DC) amounts, blood glutathione status, oxidized low-density lipoprotein (oxLDL), and total antioxidativity was measured at the baseline and after three months. A significant decrease in skin iron levels, DC amounts, and glutathione redox ratio occurred in the probiotic-supplemented group compared to the control group (P < 0.05 for all indices). In the same group, blood levels of oxLDL decreased (p < 0.05), and GSH levels increased (P < 0.001) with concomitant improvement in the GSSG/GSH ratio. Blood antioxidativity markers also showed an improvement. The results of our study demonstrate that regular use of probiotics with antioxidative properties coupled with the use of lipid-containing emollients considerably decreases inflammation and concomitant oxidative stress in adult patients with mild-to-moderate atopic dermatitis. This effect was observed both in the skin and in the blood.
[1] Proksch E., Fölster-Holst R., Jensen J-M., Skin barrier function, epidermal proliferation and differentiation in eczema, J. Dermatol. Sci., 2006, 43, 159–169 http://dx.doi.org/10.1016/j.jdermsci.2006.06.00310.1016/j.jdermsci.2006.06.003Search in Google Scholar PubMed
[2] Leung D.Y.M., Boguniewicz M., Howell M.D., Nomura I., Hamid Q. A., New insights into atopic dermatitis, J. Clin. Invest., 2004, 113, 651–7 10.1172/JCI21060Search in Google Scholar PubMed PubMed Central
[3] Isolauri E., Probiotics in human disease, Am. J. Clin. Nutr., 2001, 73, 1142S–6S 10.1093/ajcn/73.6.1142SSearch in Google Scholar PubMed
[4] Cork M.J., Robinson D.A., Vasilopoulos Y., Ferguson A., Moustafa M., MacGowan A., et al., New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions, J. Allergy Clin. Immunol., 2006, 118, 3–21 http://dx.doi.org/10.1016/j.jaci.2006.04.04210.1016/j.jaci.2006.04.042Search in Google Scholar PubMed
[5] Isolauri E., Arvola T., Sütas Y., Moilanen E., Salminen S., Probiotics in the management of atopic eczema, Clin. Exp. Allergy, 2000, 30, 1604–10 http://dx.doi.org/10.1046/j.1365-2222.2000.00943.x10.1046/j.1365-2222.2000.00943.xSearch in Google Scholar PubMed
[6] Rosenfeldt V., Benfeldt E., Nielsen D.M., Michaelsen K.F., Jeppesen D.L., Valerius N.H., et al., Effect of probiotic Lactobacillus strains in children with atopic dermatitis, J. Allergy Clin. Immunol., 2003, 111, 389–95 http://dx.doi.org/10.1067/mai.2003.38910.1067/mai.2003.389Search in Google Scholar PubMed
[7] Weston S., Halbert A., Richmond P., Prescott S. L., Effects of probiotics on atopic dermatitis: a randomized controlled trial, Arch. Dis. Child, 2005, 90, 892–897 http://dx.doi.org/10.1136/adc.2004.06067310.1136/adc.2004.060673Search in Google Scholar PubMed PubMed Central
[8] Prescott S.L., Björksten B., Probiotics for the prevention or treatment of allergic diseases, J. Allergy Clin. Immunol., 2007, 120, 255–262 http://dx.doi.org/10.1016/j.jaci.2007.04.02710.1016/j.jaci.2007.04.027Search in Google Scholar PubMed
[9] Peuhkuri K., Lähteenmäki T., Sievi E., Saxelin M., Vapaatalo H., Korpela R., Antioxidative properties of lactobacillus GG measured as prostacyclin and nitric oxide production in endothelial cell culture, Nutr. Today, 1996, 31, 53S–54S http://dx.doi.org/10.1097/00017285-199611001-0001210.1097/00017285-199611001-00012Search in Google Scholar
[10] Kullisaar T., Zilmer M., Mikelsaar M., Vihalemm T., Annuk H., Kairane C., et al., Two antioxidative lactobacilli strains as promising probiotics, Int. J. Food Microbiol., 2002, 72, 215–24 http://dx.doi.org/10.1016/S0168-1605(01)00674-210.1016/S0168-1605(01)00674-2Search in Google Scholar PubMed
[11] Kullisaar T., Songisepp E., Mikelsaar M., Zilmer K., Vihalemm T., Zilmer M., Antioxidative probiotic fermented goats’ milk decreases oxidative stressmediated atherogenicity in human subjects, Br. J. Nutr., 2003, 90, 449–56 http://dx.doi.org/10.1079/BJN200389610.1079/BJN2003896Search in Google Scholar
[12] Severity scoring of atopic dermatitis: the SCORAD index. Consensus report of the European Task Force on Atopic Dermatitis, Dermatology, 1993, 186, 23–31 10.1159/000247298Search in Google Scholar PubMed
[13] Ristimäe T., Zilmer M., Zilmer K., Kairane C., Kullisaar T., Teesalu, R., Effects of low dose aspirin on the markers of oxidative stress, Cardiovasc. Drug Ther., 1999, 13, 485–490 http://dx.doi.org/10.1023/A:100786740215210.1023/A:1007867402152Search in Google Scholar
[14] Griffith O.W., Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine, Anal. Biochem., 1980, 106, 207–12 http://dx.doi.org/10.1016/0003-2697(80)90139-610.1016/0003-2697(80)90139-6Search in Google Scholar PubMed
[15] Kohen R., Skin antioxidants: their role in aging and in oxidative stress — new approaches for their evaluation, Biomed. Pharmacother., 1999, 53, 181–92 http://dx.doi.org/10.1016/S0753-3322(99)80087-010.1016/S0753-3322(99)80087-0Search in Google Scholar PubMed
[16] Young I.S., Woodside J.V., Antioxidants in health and disease, J. Clin. Pathol., 2001, 54, 176–86 http://dx.doi.org/10.1136/jcp.54.3.17610.1136/jcp.54.3.176Search in Google Scholar PubMed PubMed Central
[17] Luyer M.D., Buurman W.A., Hadfoune M., Speelmans G., Knol J., Jakobs J.A., et al., Strainspecific effects of probiotics on gut barrier integrity following hemorrhagic shock, Infect. Immun., 2005, 73, 3686–3692 http://dx.doi.org/10.1128/IAI.73.6.3686-3692.200510.1128/IAI.73.6.3686-3692.2005Search in Google Scholar PubMed PubMed Central
[18] Murch S.H., Probiotics as mainstream allergy therapy?, Arch. Dis. Child, 2005, 90, 881–882 http://dx.doi.org/10.1136/adc.2005.07311410.1136/adc.2005.073114Search in Google Scholar PubMed PubMed Central
[19] Ouwehand A., Isolauri E., Salminen S., The role of intestinal microflora for the development of the immune system in early childhood, Eur. J. Nutr., 2002, 41 (suppl 1), 1/32–1/37 10.1007/s00394-002-1105-4Search in Google Scholar PubMed
[20] Rachmilewitz D., Karmeli F., Shteingart S., Lee J., Takabayashi K., Raz E., Immunostimulatory oligonucleotides inhibit colonic proinflammatory cytokine production in ulcerative colitis, Inflamm. Bowel Dis., 2006, 12, 339–345 http://dx.doi.org/10.1097/01.MIB.0000217335.30689.7710.1097/01.MIB.0000217335.30689.77Search in Google Scholar PubMed
[21] Memon R.A., Staprans I., Noor M., Holleran W.M., Uchida Y., Moser A.H., et al., Infection and inflammation induce LDL oxidation in vivo, Arterioscler. Thromb. Vasc. Biol., 2000, 20, 1536–42 10.1161/01.ATV.20.6.1536Search in Google Scholar PubMed
[22] Leveque N., Robin S., Muret P., Mac-Mary S., Makki S., Humbert P., High iron and ascorbic acid concentrations in the dermis of atopic dermatitis patients, Dermatology, 2003, 207, 261–264 http://dx.doi.org/10.1159/00007308710.1159/000073087Search in Google Scholar PubMed
[23] Pastore A., Federici G., Bertini E., Piemonte F., Analysis of glutathione: implication in redox and detoxification, Clin. Chim. Acta, 2003, 333, 19–39 http://dx.doi.org/10.1016/S0009-8981(03)00200-610.1016/S0009-8981(03)00200-6Search in Google Scholar
[24] Hall A.G., The role of glutathione in the regulation of apoptosis, Eur. J. Clin. Invest., 1999, 29, 238–245 http://dx.doi.org/10.1046/j.1365-2362.1999.00447.x10.1046/j.1365-2362.1999.00447.xSearch in Google Scholar PubMed
[25] Kaur S., Zilmer M., Eisen M., Kullisaar T., Rehema A., Vihalemm T., Patients with allergic and irritant contact dermatitis are characterized by striking change of iron and oxidized glutathione status in nonlesional area of the skin, J. Invest. Dermatol., 2001, 116, 886–90 http://dx.doi.org/10.1046/j.0022-202x.2001.01374.x10.1046/j.0022-202x.2001.01374.xSearch in Google Scholar PubMed
[26] Rhie G., Shin M.H., Seo J.Y., Choi W.W., Cho K.H., Kim K.H., et al., Aging-and photoaging-dependent changes of enzymic and nonenzymic antioxidants in the epidermis and dermis of human skin in vivo, J. Invest. Dermatol., 2001, 117, 1212–1217 http://dx.doi.org/10.1046/j.0022-202x.2001.01469.x10.1046/j.0022-202x.2001.01469.xSearch in Google Scholar PubMed
[27] Nogués M.R., Giralt M., Cervelló I., Del Castillo D., Espeso O., Argany N., et al., Parameters related to oxygen free radicals in human skin: a study comparing healthy epidermis and skin cancer tissue, J. Invest. Dermatol., 2002, 119, 645–652 http://dx.doi.org/10.1046/j.1523-1747.2002.00077.x10.1046/j.1523-1747.2002.00077.xSearch in Google Scholar PubMed
[28] Bengtsson Å, Lundberg M., Avila-Carino J., Jacobsson G., Holmgren A., Scheynius A., Thiols decrease cytokine levels and down-regulate the expression of CG30 on human allergen-specific T helper (Th) 0 and Th2 cells, Clin. Exp. Immunol., 2001, 123, 350–360 http://dx.doi.org/10.1046/j.1365-2249.2001.01453.x10.1046/j.1365-2249.2001.01453.xSearch in Google Scholar PubMed PubMed Central
© 2008 Versita Warsaw
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
